Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials.

Palacio S, Hart RG, Pearce LA, Anderson DC, Sharma M, Birnbaum LA, Benavente OR.

Int J Stroke. 2015 Jul;10(5):686-91. doi: 10.1111/ijs.12050.

2.

Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.

Bowry AD, Brookhart MA, Choudhry NK.

Am J Cardiol. 2008 Apr 1;101(7):960-6. doi: 10.1016/j.amjcard.2007.11.057. Review.

PMID:
18359315
3.

Effect of addition of clopidogrel to aspirin on subdural hematoma: meta-analysis of randomized clinical trials.

Bakheet MF, Pearce LA, Hart RG.

Int J Stroke. 2015 Jun;10(4):501-5. doi: 10.1111/ijs.12419.

PMID:
25472690
4.

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

SPS3 Investigators., Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA.

N Engl J Med. 2012 Aug 30;367(9):817-25. doi: 10.1056/NEJMoa1204133.

5.

Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.

Gouya G, Arrich J, Wolzt M, Huber K, Verheugt FW, Gurbel PA, Pirker-Kees A, Siller-Matula JM.

Stroke. 2014 Feb;45(2):492-503. doi: 10.1161/STROKEAHA.113.002590. Review.

6.
7.

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

Keller TT, Squizzato A, Middeldorp S.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005158. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD005158.

PMID:
17636787
8.

Efficacy and safety of adding clopidogrel to aspirin on stroke prevention among high vascular risk patients: a meta-analysis of randomized controlled trials.

Chen S, Shen Q, Tang Y, He L, Li Y, Li H, Li M, Peng Y.

PLoS One. 2014 Aug 11;9(8):e104402. doi: 10.1371/journal.pone.0104402.

9.

Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.

Zhang Q, Wang C, Zheng M, Li Y, Li J, Zhang L, Shang X, Yan C.

Cerebrovasc Dis. 2015;39(1):13-22. doi: 10.1159/000369778. Review. Erratum in: Cerebrovasc Dis. 2015;39(3-4):249-51.

10.

Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke.

Li J, Wang Y, Wang D, Lin J, Wang A, Zhao X, Liu L, Wang C, Wang Y; CHANCE Investigators..

Neurology. 2015 Mar 31;84(13):1330-6. doi: 10.1212/WNL.0000000000001421.

PMID:
25740863
13.

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ; CREDO Investigators. Clopidogrel for the Reduction of Events During Observation..

JAMA. 2002 Nov 20;288(19):2411-20. Erratum in: JAMA. 2003 Feb 26;289(8):987..

PMID:
12435254
14.

Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable.

Connolly SJ, Eikelboom JW, Ng J, Hirsh J, Yusuf S, Pogue J, de Caterina R, Hohnloser S, Hart RG; ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) Steering Committee and Investigators..

Ann Intern Med. 2011 Nov 1;155(9):579-86. doi: 10.7326/0003-4819-155-9-201111010-00004.

PMID:
22041946
15.

Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease.

Alcocer F, Novak Z, Combs BR, Lowman B, Passman MA, Mujib M, Jordan WD.

J Vasc Surg. 2014 Apr;59(4):950-5. doi: 10.1016/j.jvs.2013.10.087.

16.

Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis.

Gandhi S, Schwalm JD, Velianou JL, Natarajan MK, Farkouh ME.

Can J Cardiol. 2015 Jun;31(6):775-84. doi: 10.1016/j.cjca.2015.01.014. Review.

PMID:
25913473
17.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

18.

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

Squizzato A, Keller T, Romualdi E, Middeldorp S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD005158. doi: 10.1002/14651858.CD005158.pub3. Review.

PMID:
21249668
19.

Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.

Reaume KT, Regal RE, Dorsch MP.

Ann Pharmacother. 2008 Apr;42(4):550-7. doi: 10.1345/aph.1K433. Review.

PMID:
18319394
Items per page

Supplemental Content

Support Center